Amoéba Calls for a Key General Meeting for its Biocontrol Strategy
Amoéba announces the holding of its Ordinary and Extraordinary General Meeting on April 3, 2026. This summons comes in a context where the greentech continues its regulatory deployment in the biocontrol and cosmetics markets.
Details of the Meeting
The meeting will be held on Friday, April 3, 2026, at 9:00 AM at Amoéba's headquarters in Chassieu (69680). The notice of meeting including the agenda and draft resolutions was published in the BALO on March 18, 2026. The documents and information required by the Commercial Code are made available to shareholders in accordance with applicable regulatory provisions and published on the company's website.
Electronic Voting Process
Electronic voting via the secure VOTACCESS platform will be open from Wednesday, March 18, 2026, at 12:00 PM until Thursday, April 2, 2026, at 3:00 PM (Paris time). Shareholders wishing to use this platform can consult the access procedures on the notice of meeting and on the company's website.
